Published in Exp Ther Med on March 16, 2015
Long-term outcomes of rotational atherectomy in coronary bifurcation lesions. Exp Ther Med (2015) 0.75
Protective effect of active perfusion in porcine models of acute myocardial ischemia. Mol Med Rep (2016) 0.75
Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. N Engl J Med (2014) 10.54
Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol (1996) 4.67
Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs Cooperative Study. J Am Coll Cardiol (2004) 2.99
Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC Trial. J Am Coll Cardiol (2007) 2.34
A randomized controlled trial of a paclitaxel-eluting stent versus a similar bare-metal stent in saphenous vein graft lesions the SOS (Stenting of Saphenous Vein Grafts) trial. J Am Coll Cardiol (2009) 2.29
Coronary bypass graft fate: long-term angiographic study. J Am Coll Cardiol (1991) 2.13
Contemporary results show repeat coronary artery bypass grafting remains a risk factor for operative mortality. Ann Thorac Surg (2009) 1.69
Saphenous vein graft intervention. JACC Cardiovasc Interv (2011) 1.69
Percutaneous coronary intervention in native arteries versus bypass grafts in prior coronary artery bypass grafting patients: a report from the National Cardiovascular Data Registry. JACC Cardiovasc Interv (2011) 1.66
Safety and efficacy of drug eluting stents compared with bare metal stents for saphenous vein graft interventions: a comprehensive meta-analysis of randomized trials and observational studies comprising 7,994 patients. Catheter Cardiovasc Interv (2010) 1.46
Frequency of repeat coronary bypass or coronary angioplasty after coronary artery bypass surgery using saphenous venous grafts. Am J Cardiol (1994) 1.25
Atherosclerosis and late closure of aortocoronary saphenous vein grafts: sequential angiographic studies at 2 weeks, 1 year, 5 to 7 years, and 10 to 12 years after surgery. Circulation (1983) 1.14
Balloon angioplasty for the treatment of lesions in saphenous vein bypass grafts. J Am Coll Cardiol (1993) 1.11
Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial. J Am Coll Cardiol (2006) 1.07
Chronic total occlusion treatment in post-CABG patients: saphenous vein graft versus native vessel recanalization-long-term follow-up in the drug-eluting stent era. Catheter Cardiovasc Interv (2007) 0.89
Occurrence and risk factors for reintervention after coronary artery bypass grafting. Circulation (2006) 0.87
Short- and long-term outcomes after stent-assisted percutaneous treatment of saphenous vein grafts in the drug-eluting stent era. Am J Cardiol (2007) 0.85
Percutaneous coronary intervention versus coronary bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: The VA AWESOME multicenter registry: comparison with the randomized clinical trial. J Am Coll Cardiol (2002) 0.84
Percutaneous treatment of saphenous vein graft disease: the ongoing challenge. J Am Coll Cardiol (2003) 0.83
Long-term outcomes of drug-eluting stents versus bare-metal stents in saphenous vein graft disease: results from the Prairie "Real World" Stent Registry. Catheter Cardiovasc Interv (2010) 0.82
Percutaneous saphenous vein graft intervention--a review. Heart Lung Circ (2007) 0.81
Long-term safety and effectiveness of drug-eluting stents for the treatment of saphenous vein grafts disease: a population-based study. JACC Cardiovasc Interv (2011) 0.81
Implantation of sirolimus-eluting stents in saphenous vein grafts is associated with high clinical follow-up event rates compared with treatment of native vessels. Coron Artery Dis (2007) 0.81
Long-term clinical outcome after percutaneous coronary intervention in grafts vs native vessels in patients with previous coronary artery bypass grafting. Can J Cardiol (2011) 0.80
Saphenous vein graft intervention: a review. J Invasive Cardiol (2012) 0.78
Percutaneous revascularization strategies in saphenous vein graft lesions: long-term results. Rev Port Cardiol (2011) 0.78
Percutaneous revascularization improves outcomes in patients with prior coronary artery bypass surgery. Catheter Cardiovasc Interv (2012) 0.78
[Comparison of drug-eluting and bare metal stents in saphenous vein grafts. Immediate and long-term results]. Rev Esp Cardiol (2009) 0.78
Comparison of drug-eluting and bare metal stents for saphenous vein graft lesions (from the National Heart, Lung, and Blood Institute Dynamic Registry). Am J Cardiol (2010) 0.77
Drug-eluting stenting of saphenous vein graft versus native coronary artery supplying the same myocardial perfusion territory: a pilot retrospective 3-year follow-up. J Invasive Cardiol (2012) 0.77
The quest for optimal interventional strategy in saphenous vein graft interventions--are we there yet? Catheter Cardiovasc Interv (2012) 0.77
Long-term follow-up of lesion-specific outcomes comparing drug-eluting stents and bare metal stents in diseased saphenous vein grafts. Rev Cardiovasc Med (2013) 0.77